Related Experiment Video
Updated: Feb 21, 2026

RhoC GTPase Activation Assay
Published on: August 22, 2010
Rab25 GTPase: Functional roles in cancer
Sisi Wang1, Chunhong Hu1, Fang Wu1
1Department of Oncology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China.
Abstract:
Rab25, a small GTPase belongs to the Rab protein family, has a pivotal role in cancer pathophysiology. Rab25 governs cell-surface receptors recycling and cellular signaling pathways activation, allowing it to control a diverse range of cellular functions, including cell proliferation, cell motility and cell death. Aberrant expression of Rab25 was linked to cancer development. Majority of research findings revealed that Rab25 is an oncogene. Elevated expression of Rab25 was correlated with poor prognosis and aggressiveness of renal, lung, breast, ovarian and other cancers. However, tumor suppressor function of Rab25 was reported in several cancers, such as colorectal cancer, indicating the tumor type-specific function of Rab25. In this review, we recapitulate the current knowledge of Rab25 in cancer development and therapy.
Insights
Rab25, a small GTPase, plays a dual role in cancer, acting as an oncogene in many cancers but a tumor suppressor in others. This review summarizes Rab25
Area of Science:
- Molecular Biology
- Oncology
- Cell Biology
Background:
- Rab25, a small GTPase, is integral to the Rab protein family and influences cancer pathophysiology.
- It regulates cell-surface receptor recycling and signaling pathways, impacting cell proliferation, motility, and death.
- Aberrant Rab25 expression is linked to cancer development, with most studies identifying it as an oncogene.
Purpose of the Study:
- To review the current understanding of Rab25's role in cancer development.
- To summarize the known functions of Rab25 in various cancer types.
- To discuss the implications of Rab25 in cancer therapy.
Main Methods:
- Literature review of existing research on Rab25 in cancer.
- Analysis of studies reporting Rab25 expression levels and patient prognosis.
- Synthesis of findings on Rab25's oncogenic and tumor-suppressive functions.
Main Results:
- Elevated Rab25 expression correlates with poor prognosis and aggressiveness in renal, lung, breast, and ovarian cancers.
- Rab25 functions as an oncogene in the majority of cancers studied.
- Conversely, Rab25 exhibits tumor suppressor activity in certain cancers, such as colorectal cancer, highlighting its context-dependent role.
Conclusions:
- Rab25 has a complex, tumor-type-specific role in cancer.
- Understanding Rab25's dual function is crucial for developing targeted cancer therapies.
- Further research is needed to fully elucidate Rab25's mechanisms in different cancer contexts.
More Related Videos
13:51Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
10:27Spatio-Temporal Manipulation of Small GTPase Activity at Subcellular Level and on Timescale of Seconds in Living Cells
Published on: March 9, 2012
Related Concept Videos
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
Rab Cascades
The Ras Gene
Ras is a...
GTPases and their Regulation
Large G-proteins,...
GTPases and their Regulation